Delhi Health Department aims for 1.49 lakh HPV vaccinations in 100 days
Delhi sets target for 1.49 lakh HPV vaccinations in 100 days to combat cervical cancer. A proactive step for public health awareness.
The Delhi Health Department has set an ambitious target to administer 1.49 lakh HPV vaccinations within 100 days as part of its intensified efforts to combat cervical cancer. The initiative, aimed at vaccinating adolescent girls aged 9 to 14 years, is being rolled out across government and private schools in the National Capital Region. Officials have described the campaign as a significant step towards improving public health outcomes for women in the city.
HPV, or human papillomavirus, is a leading cause of cervical cancer, which remains one of the most common cancers affecting women globally. The vaccine is most effective when administered before individuals become sexually active, making the targeted age group critical for prevention. The Delhi government has urged schools to cooperate fully in identifying eligible students and ensuring smooth implementation of the program.
This vaccination drive aligns with India's broader public health goals. In June this year, the Union Health Ministry launched the country's first indigenously developed HPV vaccine, Cervavac, which is priced significantly lower than imported alternatives. The central government aims to include the vaccine in the Universal Immunisation Programme, making it accessible to millions of girls nationwide. Delhi's campaign is seen as a model for other states to follow.
Experts have lauded the initiative, highlighting the importance of early intervention in reducing cervical cancer cases and associated mortality rates. "This is a commendable move by the Delhi government. HPV vaccination can save countless lives and reduce the burden on healthcare systems," said a senior oncologist at AIIMS.
The vaccination program also reflects growing awareness about women's health issues in India, where cervical cancer accounts for nearly 25% of all female cancer deaths. By prioritizing preventive measures, the Delhi government hopes to set a precedent for proactive healthcare policies that address long-standing gaps in women's health.
Frequently asked questions
What is the Delhi Health Department's HPV vaccination target?
The Delhi Health Department aims to administer 1.49 lakh HPV vaccinations within 100 days as part of its campaign to combat cervical cancer.
Who is eligible for the HPV vaccination campaign in Delhi?
Adolescent girls aged 9 to 14 years are eligible. The vaccinations are being rolled out across government and private schools in the National Capital Region.
Why is HPV vaccination important for this age group?
The HPV vaccine is most effective when administered before individuals become sexually active. HPV is a leading cause of cervical cancer, one of the most common cancers affecting women globally.
What is Cervavac and how does it relate to this campaign?
Cervavac is India's first indigenously developed HPV vaccine, launched by the Union Health Ministry in June. It is priced significantly lower than imported alternatives and is being considered for inclusion in the Universal Immunisation Programme.
How significant is cervical cancer among female cancers in India?
Cervical cancer accounts for nearly 25% of all female cancer deaths in India, making HPV vaccination an important preventive measure for women's health.
Most read
- 1
Air China Adds Extra Flight for Passengers Stranded in Fuel-Starved Cuba
- 2
Western disturbance to bring rain, hail and strong winds across north India
- 3
Yogi Adityanath Directs No Occupied Houses Be Demolished for Achhalda Bridge
- 4
Schools Shut in Five Tamil Nadu Districts, Including Chennai, Amid Heavy Rain
- 5
Gwalior Temple Truck Crash Kills 12, Injures 28-29 Devotees During Navratri
Comments
No comments yet. Be the first to comment.